-
1
-
-
56449131391
-
Profiling the specificity of neutralizing antibodies in a large panel of plasmas from patients chronically infected with human immunodeficiency virus type 1 subtypes B and C
-
Binley JM, et al. (2008) Profiling the specificity of neutralizing antibodies in a large panel of plasmas from patients chronically infected with human immunodeficiency virus type 1 subtypes B and C. J Virol 82(23):11651-11668.
-
(2008)
J Virol
, vol.82
, Issue.23
, pp. 11651-11668
-
-
Binley, J.M.1
-
2
-
-
73949084963
-
Breadth of human immunodeficiency virus-specific neutralizing activity in sera: Clustering analysis and association with clinical variables
-
Doria-Rose NA, et al. (2010) Breadth of human immunodeficiency virus-specific neutralizing activity in sera: Clustering analysis and association with clinical variables. J Virol 84(3):1631-1636.
-
(2010)
J Virol
, vol.84
, Issue.3
, pp. 1631-1636
-
-
Doria-Rose, N.A.1
-
3
-
-
58149399396
-
Frequency and phenotype of human immunodeficiency virus envelope-specific B cells from patients with broadly cross-neutralizing antibodies
-
Doria-Rose NA, et al. (2009) Frequency and phenotype of human immunodeficiency virus envelope-specific B cells from patients with broadly cross-neutralizing antibodies. J Virol 83(1):188-199.
-
(2009)
J Virol
, vol.83
, Issue.1
, pp. 188-199
-
-
Doria-Rose, N.A.1
-
4
-
-
69249208675
-
Antibody specificities associated with neutralization breadth in plasma from human immunodeficiency virus type 1 subtype C-infected blood donors
-
Gray ES, et al. (2009) Antibody specificities associated with neutralization breadth in plasma from human immunodeficiency virus type 1 subtype C-infected blood donors. J Virol 83(17):8925-8937.
-
(2009)
J Virol
, vol.83
, Issue.17
, pp. 8925-8937
-
-
Gray, E.S.1
-
5
-
-
58149487645
-
Factors associated with the development of cross-reactive neutralizing antibodies during human immunodeficiency virus type 1 infection
-
Sather DN, et al. (2009) Factors associated with the development of cross-reactive neutralizing antibodies during human immunodeficiency virus type 1 infection. J Virol 83(2):757-769.
-
(2009)
J Virol
, vol.83
, Issue.2
, pp. 757-769
-
-
Sather, D.N.1
-
6
-
-
67650453747
-
Human immunodeficiency virus type 1 elite neutralizers: Individuals with broad and potent neutralizing activity identified by using a highthroughput neutralization assay together with an analytical selection algorithm
-
Simek MD, et al. (2009) Human immunodeficiency virus type 1 elite neutralizers: Individuals with broad and potent neutralizing activity identified by using a highthroughput neutralization assay together with an analytical selection algorithm. J Virol 83(14):7337-7348.
-
(2009)
J Virol
, vol.83
, Issue.14
, pp. 7337-7348
-
-
Simek, M.D.1
-
7
-
-
63849131879
-
Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals
-
Scheid JF, et al. (2009) Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals. Nature 458(7238):636-640.
-
(2009)
Nature
, vol.458
, Issue.7238
, pp. 636-640
-
-
Scheid, J.F.1
-
8
-
-
84857084577
-
Longitudinal analysis of early HIV-1-specific neutralizing activity in an elite neutralizer and in five patients who developed cross-reactive neutralizing activity
-
Euler Z, et al. (2012) Longitudinal analysis of early HIV-1-specific neutralizing activity in an elite neutralizer and in five patients who developed cross-reactive neutralizing activity. J Virol 86(4):2045-2055.
-
(2012)
J Virol
, vol.86
, Issue.4
, pp. 2045-2055
-
-
Euler, Z.1
-
9
-
-
79955389756
-
The neutralization breadth of HIV-1 develops incrementally over four years and is associated with CD4+ T cell decline and high viral load during acute infection
-
and the CAPRISA002 Study Team
-
Gray ES, et al.; and the CAPRISA002 Study Team (2011) The neutralization breadth of HIV-1 develops incrementally over four years and is associated with CD4+ T cell decline and high viral load during acute infection. J Virol 85(10):4828-4840.
-
(2011)
J Virol
, vol.85
, Issue.10
, pp. 4828-4840
-
-
Gray, E.S.1
-
10
-
-
58149487646
-
Continuous viral escape and selection by autologous neutralizing antibodies in drug-naive human immunodeficiency virus controllers
-
Mahalanabis M, et al. (2009) Continuous viral escape and selection by autologous neutralizing antibodies in drug-naive human immunodeficiency virus controllers. J Virol 83(2):662-672.
-
(2009)
J Virol
, vol.83
, Issue.2
, pp. 662-672
-
-
Mahalanabis, M.1
-
11
-
-
35348937119
-
Genetic characteristics of HIV-1 subtype C envelopes inducing cross-neutralizing antibodies
-
HIVNET 028 study team
-
Rademeyer C, et al.; HIVNET 028 study team (2007) Genetic characteristics of HIV-1 subtype C envelopes inducing cross-neutralizing antibodies. Virology 368(1):172-181.
-
(2007)
Virology
, vol.368
, Issue.1
, pp. 172-181
-
-
Rademeyer, C.1
-
12
-
-
84055181327
-
Rapid development of glycan-specific, broad, and potent anti-HIV-1 gp120 neutralizing antibodies in an R5 SIV/HIV chimeric virus infected macaque
-
Walker LM, et al. (2011) Rapid development of glycan-specific, broad, and potent anti-HIV-1 gp120 neutralizing antibodies in an R5 SIV/HIV chimeric virus infected macaque. Proc Natl Acad Sci USA 108(50):20125-20129.
-
(2011)
Proc Natl Acad Sci USA
, vol.108
, Issue.50
, pp. 20125-20129
-
-
Walker, L.M.1
-
13
-
-
84865096278
-
Pathogenicity and mucosal transmissibility of the R5-tropic simian/human immunodeficiency virus SHIV(AD8) in rhesus macaques: Implications for use in vaccine studies
-
Gautam R, et al. (2012) Pathogenicity and mucosal transmissibility of the R5-tropic simian/human immunodeficiency virus SHIV(AD8) in rhesus macaques: Implications for use in vaccine studies. J Virol 86(16):8516-8526.
-
(2012)
J Virol
, vol.86
, Issue.16
, pp. 8516-8526
-
-
Gautam, R.1
-
14
-
-
77950787447
-
Generation of the pathogenic R5-tropic simian/human immunodeficiency virus SHIVAD8by serial passaging in rhesusmacaques
-
Nishimura Y, et al. (2010) Generation of the pathogenic R5-tropic simian/human immunodeficiency virus SHIVAD8by serial passaging in rhesusmacaques.JVirol 84(9):4769-4781.
-
(2010)
JVirol
, vol.84
, Issue.9
, pp. 4769-4781
-
-
Nishimura, Y.1
-
15
-
-
2342625375
-
Induction of disease by a molecularly cloned highly pathogenic simian immunodeficiency virus/human immunodeficiency virus chimera is multigenic
-
Sadjadpour R, et al. (2004) Induction of disease by a molecularly cloned highly pathogenic simian immunodeficiency virus/human immunodeficiency virus chimera is multigenic. J Virol 78(10):5513-5519.
-
(2004)
J Virol
, vol.78
, Issue.10
, pp. 5513-5519
-
-
Sadjadpour, R.1
-
16
-
-
0030855058
-
Infection and pathogenicity of chimeric simian-human immunodeficiency viruses in macaques: Determinants of high virus loads and CD4 cell killing
-
Shibata R, et al. (1997) Infection and pathogenicity of chimeric simian-human immunodeficiency viruses in macaques: Determinants of high virus loads and CD4 cell killing. J Infect Dis 176(2):362-373.
-
(1997)
J Infect Dis
, vol.176
, Issue.2
, pp. 362-373
-
-
Shibata, R.1
-
17
-
-
0029018332
-
Isolation and characterization of a syncytium-inducing, macrophage/ T-cell line-tropic human immunodeficiency virus type 1 isolate that readily infects chimpanzee cells in vitro and in vivo
-
Shibata R, et al. (1995) Isolation and characterization of a syncytium-inducing, macrophage/ T-cell line-tropic human immunodeficiency virus type 1 isolate that readily infects chimpanzee cells in vitro and in vivo. J Virol 69(7):4453-4462.
-
(1995)
J Virol
, vol.69
, Issue.7
, pp. 4453-4462
-
-
Shibata, R.1
-
18
-
-
73949127978
-
Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies
-
Seaman MS, et al. (2010) Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies. J Virol 84(3):1439-1452.
-
(2010)
J Virol
, vol.84
, Issue.3
, pp. 1439-1452
-
-
Seaman, M.S.1
-
19
-
-
34249952292
-
Macaques infected with a CCR5-tropic simian/human immunodeficiency virus (SHIV) develop broadly reactive anti-HIV neutralizing antibodies
-
Kraft Z, et al. (2007) Macaques infected with a CCR5-tropic simian/human immunodeficiency virus (SHIV) develop broadly reactive anti-HIV neutralizing antibodies. J Virol 81(12):6402-6411.
-
(2007)
J Virol
, vol.81
, Issue.12
, pp. 6402-6411
-
-
Kraft, Z.1
-
20
-
-
0031901463
-
Neutralizing antibodies in sera from macaques infected with chimeric simian-human immunodeficiency virus containing the envelope glycoproteins of either a laboratory-adapted variant or a primary isolate of human immunodeficiency virus type 1
-
Montefiori DC, et al. (1998) Neutralizing antibodies in sera from macaques infected with chimeric simian-human immunodeficiency virus containing the envelope glycoproteins of either a laboratory-adapted variant or a primary isolate of human immunodeficiency virus type 1. J Virol 72(4):3427-3431.
-
(1998)
J Virol
, vol.72
, Issue.4
, pp. 3427-3431
-
-
Montefiori, D.C.1
-
21
-
-
23244434512
-
Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies
-
Li M, et al. (2005) Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies. J Virol 79(16):10108-10125.
-
(2005)
J Virol
, vol.79
, Issue.16
, pp. 10108-10125
-
-
Li, M.1
-
22
-
-
0025267919
-
Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera
-
Albert J, et al. (1990) Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera. AIDS 4(2):107-112.
-
(1990)
AIDS
, vol.4
, Issue.2
, pp. 107-112
-
-
Albert, J.1
-
23
-
-
49149118421
-
Autologous neutralizing humoral immunity and evolution of the viral envelope in the course of subtype B human immunodeficiency virus type 1 infection
-
Bunnik EM, Pisas L, van Nuenen AC, Schuitemaker H (2008) Autologous neutralizing humoral immunity and evolution of the viral envelope in the course of subtype B human immunodeficiency virus type 1 infection. J Virol 82(16):7932-7941.
-
(2008)
J Virol
, vol.82
, Issue.16
, pp. 7932-7941
-
-
Bunnik, E.M.1
Pisas, L.2
Van Nuenen, A.C.3
Schuitemaker, H.4
-
24
-
-
0025854294
-
Homotypic antibody responses to fresh clinical isolates of human immunodeficiency virus
-
Montefiori DC, et al. (1991) Homotypic antibody responses to fresh clinical isolates of human immunodeficiency virus. Virology 182(2):635-643.
-
(1991)
Virology
, vol.182
, Issue.2
, pp. 635-643
-
-
Montefiori, D.C.1
-
25
-
-
79551518897
-
Characteristics of the earliest cross-neutralizing antibody response to HIV-1
-
Mikell I, et al. (2011) Characteristics of the earliest cross-neutralizing antibody response to HIV-1. PLoS Pathog 7(1):e1001251.
-
(2011)
PLoS Pathog
, vol.7
, Issue.1
-
-
Mikell, I.1
-
26
-
-
0037108952
-
Amino acid deletions are introduced into the V2 region of gp120 during independent pathogenic simian immunodeficiency virus/HIV chimeric virus (SHIV) infections of rhesus monkeys generating variants that are macrophage tropic
-
Imamichi H, et al. (2002) Amino acid deletions are introduced into the V2 region of gp120 during independent pathogenic simian immunodeficiency virus/HIV chimeric virus (SHIV) infections of rhesus monkeys generating variants that are macrophage tropic. Proc Natl Acad Sci USA 99(21):13813-13818.
-
(2002)
Proc Natl Acad Sci USA
, vol.99
, Issue.21
, pp. 13813-13818
-
-
Imamichi, H.1
-
27
-
-
0003633755
-
-
Committee on Care and Use of Laboratory Animals National Institutes of Health, Bethesda, MD DHHs Publ. No. NIH 85-23, Revised Ed.
-
Committee on Care and Use of Laboratory Animals (1985) Guide for the Care and Use of Laboratory Animals (National Institutes of Health, Bethesda, MD) DHHs Publ. No. NIH 85-23, Revised Ed.
-
(1985)
Guide for the Care and Use of Laboratory Animals
-
-
-
28
-
-
0033942484
-
Short- and long-term clinical outcomes in rhesus monkeys inoculated with a highly pathogenic chimeric simian/human immunodeficiency virus
-
Endo Y, et al. (2000) Short- and long-term clinical outcomes in rhesus monkeys inoculated with a highly pathogenic chimeric simian/human immunodeficiency virus. J Virol 74(15):6935-6945.
-
(2000)
J Virol
, vol.74
, Issue.15
, pp. 6935-6945
-
-
Endo, Y.1
-
29
-
-
10744233668
-
Macrophage-tropic simian/human immunodeficiency virus chimeras use CXCR4, not CCR5, for infections of rhesus macaque peripheral blood mononuclear cells and alveolar macrophages
-
Igarashi T, et al. (2003) Macrophage-tropic simian/human immunodeficiency virus chimeras use CXCR4, not CCR5, for infections of rhesus macaque peripheral blood mononuclear cells and alveolar macrophages. J Virol 77(24):13042-13052.
-
(2003)
J Virol
, vol.77
, Issue.24
, pp. 13042-13052
-
-
Igarashi, T.1
-
30
-
-
20344375938
-
Resting naive CD4+ T cells are massively infected and eliminated by X4-tropic simian-human immunodeficiency viruses in macaques
-
Nishimura Y, et al. (2005) Resting naive CD4+ T cells are massively infected and eliminated by X4-tropic simian-human immunodeficiency viruses in macaques. Proc Natl Acad Sci USA 102(22):8000-8005.
-
(2005)
Proc Natl Acad Sci USA
, vol.102
, Issue.22
, pp. 8000-8005
-
-
Nishimura, Y.1
-
31
-
-
33846061212
-
Loss of naïve cells accompanies memory CD4+ T-cell depletion during long-term progression to AIDS in Simian immunodeficiency virus-infected macaques
-
Nishimura Y, et al. (2007) Loss of naïve cells accompanies memory CD4+ T-cell depletion during long-term progression to AIDS in Simian immunodeficiency virus-infected macaques. J Virol 81(2):893-902.
-
(2007)
J Virol
, vol.81
, Issue.2
, pp. 893-902
-
-
Nishimura, Y.1
-
32
-
-
4344592775
-
Highly pathogenic SHIVs and SIVs target different CD4+ T cell subsets in rhesus monkeys, explaining their divergent clinical courses
-
Nishimura Y, et al. (2004) Highly pathogenic SHIVs and SIVs target different CD4+ T cell subsets in rhesus monkeys, explaining their divergent clinical courses. Proc Natl Acad Sci USA 101(33):12324-12329.
-
(2004)
Proc Natl Acad Sci USA
, vol.101
, Issue.33
, pp. 12324-12329
-
-
Nishimura, Y.1
-
33
-
-
33846087269
-
Efficient protein boosting after plasmid DNA or recombinant adenovirus immunization with HIV-1 vaccine constructs
-
Shu Y, et al. (2007) Efficient protein boosting after plasmid DNA or recombinant adenovirus immunization with HIV-1 vaccine constructs. Vaccine 25(8):1398-1408.
-
(2007)
Vaccine
, vol.25
, Issue.8
, pp. 1398-1408
-
-
Shu, Y.1
-
34
-
-
0036090585
-
Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy
-
Wei X, et al. (2002) Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob Agents Chemother 46(6):1896-1905.
-
(2002)
Antimicrob Agents Chemother
, vol.46
, Issue.6
, pp. 1896-1905
-
-
Wei, X.1
-
35
-
-
76449108010
-
Neutralizing antibody titers conferring protection to macaques from a simian/human immunodeficiency virus challenge using the TZM-bl assay
-
Willey R, Nason MC, Nishimura Y, Follmann DA, Martin MA (2010) Neutralizing antibody titers conferring protection to macaques from a simian/human immunodeficiency virus challenge using the TZM-bl assay. AIDS Res Hum Retroviruses 26(1):89-98.
-
(2010)
AIDS Res Hum Retroviruses
, vol.26
, Issue.1
, pp. 89-98
-
-
Willey, R.1
Nason, M.C.2
Nishimura, Y.3
Follmann, D.A.4
Martin, M.A.5
-
36
-
-
70350320690
-
Mechanism of human immunodeficiency virus type 1 resistance to monoclonal antibody B12 that effectively targets the site of CD4 attachment
-
Wu X, et al. (2009) Mechanism of human immunodeficiency virus type 1 resistance to monoclonal antibody B12 that effectively targets the site of CD4 attachment. J Virol 83(21):10892-10907.
-
(2009)
J Virol
, vol.83
, Issue.21
, pp. 10892-10907
-
-
Wu, X.1
-
37
-
-
78049370371
-
Neutralization activity in a geographically diverse East London cohort of human immunodeficiency virus type 1-infected patients: Clade C infection results in a stronger and broader humoral immune response than clade B infection
-
Dreja H, et al. (2010) Neutralization activity in a geographically diverse East London cohort of human immunodeficiency virus type 1-infected patients: Clade C infection results in a stronger and broader humoral immune response than clade B infection. J Gen Virol 91(Pt 11):2794-2803.
-
(2010)
J Gen Virol
, vol.91
, Issue.PART 11
, pp. 2794-2803
-
-
Dreja, H.1
|